These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 12649149)

  • 41. [Regulation of T-cell activation by CD28 and CTLA-4].
    Nagel T; Kalden JR; Manger B
    Med Klin (Munich); 1998 Oct; 93(10):592-7. PubMed ID: 9849050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system.
    Anderson DE; Sharpe AH; Hafler DA
    Curr Opin Immunol; 1999 Dec; 11(6):677-83. PubMed ID: 10631554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CTLA-4Ig: uses and future directions.
    Ben-Shoshan M
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):132-42. PubMed ID: 19519590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
    Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
    Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
    Chang TT; Kuchroo VK; Sharpe AH
    Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
    [No Abstract]   [Full Text] [Related]  

  • 47. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.
    Qureshi OS; Zheng Y; Nakamura K; Attridge K; Manzotti C; Schmidt EM; Baker J; Jeffery LE; Kaur S; Briggs Z; Hou TZ; Futter CE; Anderson G; Walker LS; Sansom DM
    Science; 2011 Apr; 332(6029):600-3. PubMed ID: 21474713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
    Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses.
    Blazevic V; Trubey CM; Shearer GM
    J Clin Immunol; 2001 Jul; 21(4):293-302. PubMed ID: 11506200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of costimulatory molecules on dendritic cells: implications for tolerance induction.
    Luke PP; Thomson AW
    Transplant Proc; 2001; 33(1-2):507-8. PubMed ID: 11266929
    [No Abstract]   [Full Text] [Related]  

  • 52. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
    Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
    Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD80 costimulation is essential for the induction of airway eosinophilia.
    Harris N; Peach R; Naemura J; Linsley PS; Le Gros G; Ronchese F
    J Exp Med; 1997 Jan; 185(1):177-82. PubMed ID: 8996254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
    Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.
    Freeman GJ; Borriello F; Hodes RJ; Reiser H; Hathcock KS; Laszlo G; McKnight AJ; Kim J; Du L; Lombard DB
    Science; 1993 Nov; 262(5135):907-9. PubMed ID: 7694362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
    Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R
    Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
    Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
    J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae.
    Wu ZQ; Khan AQ; Shen Y; Schartman J; Peach R; Lees A; Mond JJ; Gause WC; Snapper CM
    J Immunol; 2000 Dec; 165(12):6840-8. PubMed ID: 11120807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
    Schaub M; Stadlbauer TH; Chandraker A; Vella JP; Turka LA; Sayegh MH
    J Am Soc Nephrol; 1998 May; 9(5):891-8. PubMed ID: 9596088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.